RxDoctor Payments Data

Vickie Harrell, MD

Internal Medicine · Panama City, FLNPI 1730155060

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 124 payments — averaging $12.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Merck$140
  • Lilly USA, LLC$35
  • AstraZeneca$34
  • Bayer$22
  • Abbott$20
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$1,56999%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,580 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$330,461
Medicare patients
478
Services billed
4,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide121$153,915
JardianceEmpagliflozin106$103,362
EliquisApixaban83$86,376
TrulicityDulaglutide19$43,445
XareltoRivaroxaban38$39,504
MounjaroTirzepatide30$31,295
JanuviaSitagliptin Phosphate13$17,013
Tresiba Flextouch U-200Insulin Degludec35$13,562
LivaloPitavastatin Calcium20$10,181
Breo ElliptaFluticasone/Vilanterol20$7,896
SynthroidLevothyroxine Sodium78$7,288
Rosuvastatin Calcium401$6,689
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$4,910
Gabapentin329$4,850
Advair HfaFluticasone Propion/Salmeterol16$4,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,301$153,915121 claims
Lilly USA, LLCTrulicity, Mounjaro$35$74,74049 claims
MerckJanuvia$140$17,01313 claims
AbbVieSynthroid$14$7,28878 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Panama City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →